DocGo (DCGO) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

DCGO Stock Forecast

DocGo stock forecast is as follows: an average price target of $8.75 (represents a 104.92% upside from DCGO’s last price of $4.27) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

DCGO Price Target

The average price target for DocGo (DCGO) is $8.75 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $5.00. This represents a potential 104.92% upside from DCGO's last price of $4.27.

DCGO Analyst Ratings

Buy

According to 2 Wall Street analysts, DocGo's rating consensus is 'Buy'. The analyst rating breakdown for DCGO stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

DocGo Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 09, 2024	Richard Close	Canaccord Genuity	$5.00	$3.50	42.86%	17.10%
Apr 10, 2024	David Grossman	Stifel Nicolaus	$8.00	$3.17	152.45%	87.35%
Apr 10, 2024	David Larsen	BTIG	$11.00	$3.85	185.71%	157.61%
Apr 19, 2022		Deutsche Bank	$11.00	$8.11	35.64%	157.61%

The latest DocGo stock forecast, released on May 09, 2024 by Richard Close from Canaccord Genuity, set a price target of $5.00, which represents a 42.86% increase from the stock price at the time of the forecast ($3.50), and a 17.10% increase from DCGO last price ($4.27).

DocGo Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	3
Avg Price Target	-	-	$8.00
Last Closing Price	$4.27	$4.27	$4.27
Upside/Downside	-100.00%	-100.00%	87.35%

In the current month, the average price target of DocGo stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DocGo's last price of $4.27. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
May 09, 2024	Canaccord Genuity	Buy	Buy	Hold
Sep 19, 2023	BTIG	Buy	Buy	Hold

DocGo's last stock rating was published by Canaccord Genuity on May 09, 2024. The company gave DCGO a "Buy" rating, the same as its previous rate.

DocGo Financial Forecast

DocGo Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$199.25T	$186.55T	$125.49M	$113.00M	$108.78M	$104.32M	$109.52M	$117.89M	$121.32M
Avg Forecast	$116.32M	$119.55M	$116.29M	$114.41M	$107.49M	$102.06M	$106.08M	$111.93M	$129.42M	$137.84M	$163.38M	$187.95M	$194.21M	$147.69M	$119.77M	$111.53M	$104.90M	$97.77M	$97.94M	$103.84M	$81.06M
High Forecast	$122.08M	$125.47M	$122.05M	$120.07M	$112.81M	$107.11M	$111.33M	$113.22M	$130.84M	$137.88M	$163.38M	$187.95M	$195.33M	$147.69M	$125.70M	$117.05M	$110.09M	$97.77M	$97.94M	$103.84M	$81.06M
Low Forecast	$111.83M	$114.94M	$111.80M	$110.00M	$103.34M	$98.12M	$101.99M	$110.65M	$127.27M	$137.80M	$163.38M	$187.95M	$192.28M	$147.69M	$115.15M	$107.22M	$100.85M	$97.77M	$97.94M	$103.84M	$81.06M
# Analysts	2	2	2	2	1	1	1	4	5	4	4	4	5	4	4	4	3	3	3	3	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1025912.34%	1263122.95%	1.05%	1.01%	1.04%	1.07%	1.12%	1.14%	1.50%

DocGo's average Quarter revenue forecast for Mar 24 based on 4 analysts is $187.95M, with a low forecast of $187.95M, and a high forecast of $187.95M. DCGO's average Quarter revenue forecast represents a -100.00% decrease compared to the company's last Quarter revenue of $199.25T (Dec 23).

DocGo EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	2	2	2	2	1	1	1	4	5	4	4	4	5	4	4	4	3	3	3	3	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$16.82T	$13.49T	$5.51M	$-3.20M	$6.39M	$9.00M	$6.47M	$12.35M	$24.86M
Avg Forecast	$-5.33M	$-5.48M	$-5.33M	$-5.24M	$-4.93M	$-4.68M	$-4.86M	$-5.13M	$-5.93M	$-6.32M	$-7.49M	$-8.61M	$-8.90M	$-6.77M	$-5.49M	$-5.11M	$-4.81M	$-5.16M	$-5.16M	$7.32M	$-4.27M
High Forecast	$-5.12M	$-5.27M	$-5.12M	$-5.04M	$-4.74M	$-4.50M	$-4.67M	$-5.07M	$-5.83M	$-6.31M	$-7.49M	$-8.61M	$-8.81M	$-6.77M	$-5.28M	$-4.91M	$-4.62M	$-5.16M	$-5.16M	$8.78M	$-4.27M
Low Forecast	$-5.59M	$-5.75M	$-5.59M	$-5.50M	$-5.17M	$-4.91M	$-5.10M	$-5.19M	$-6.00M	$-6.32M	$-7.49M	$-8.61M	$-8.95M	$-6.77M	$-5.76M	$-5.36M	$-5.04M	$-5.16M	$-5.16M	$5.86M	$-4.27M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-1889799.32%	-1993732.27%	-1.00%	0.63%	-1.33%	-1.75%	-1.25%	1.69%	-5.82%

4 analysts predict DCGO's average Quarter EBITDA for Mar 24 to be $-8.61M, with a high of $-8.61M and a low of $-8.61M. This is -100.00% lower than DocGo's previous annual EBITDA (Dec 23) of $16.82T.

DocGo Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	2	2	2	2	1	1	1	4	5	4	4	4	5	4	4	4	3	3	3	3	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$16.40T	$13.68T	$-2.01M	$-3.92M	$8.06M	$2.47M	$12.74M	$10.63M	$20.27M
Avg Forecast	$4.25M	$4.25M	$4.25M	$4.25M	$2.55M	$1.91M	$1.06M	$1.91M	$4.25M	$4.25M	$6.02M	$8.15M	$10.45M	$6.55M	$2.98M	$1.89M	$7.52M	$4.82M	$3.88M	$6.94M	$201.12M
High Forecast	$4.53M	$4.53M	$4.53M	$4.53M	$2.72M	$2.04M	$1.13M	$2.04M	$4.53M	$4.53M	$6.41M	$8.38M	$13.67M	$6.70M	$3.17M	$2.01M	$8.00M	$4.82M	$3.88M	$8.33M	$201.12M
Low Forecast	$4.04M	$4.04M	$4.04M	$4.04M	$2.42M	$1.82M	$1.01M	$1.82M	$3.19M	$4.04M	$5.72M	$7.92M	$7.24M	$6.41M	$2.83M	$1.79M	$7.14M	$4.82M	$3.88M	$5.55M	$201.12M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1569044.34%	2087646.13%	-0.68%	-2.08%	1.07%	0.51%	3.28%	1.53%	0.10%

DocGo's average Quarter net income forecast for Mar 24 is $8.15M, with a range of $7.92M to $8.38M. DCGO's average Quarter net income forecast represents a -100.00% decrease compared to the company's last Quarter net income of $16.40T (Dec 23).

DocGo SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	2	2	2	2	1	1	1	4	5	4	4	4	5	4	4	4	3	3	3	3	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$43.72T	$35.23T	$33.89M	$33.17M	$37.30M	$24.48M	$28.70M	$26.47M	$30.64M
Avg Forecast	$41.47M	$42.62M	$41.46M	$40.79M	$38.32M	$36.39M	$37.82M	$39.91M	$46.14M	$49.14M	$58.25M	$67.01M	$69.24M	$52.66M	$42.70M	$39.76M	$37.40M	$34.86M	$34.92M	$16.41M	$28.90M
High Forecast	$43.52M	$44.73M	$43.51M	$42.81M	$40.22M	$38.19M	$39.69M	$40.37M	$46.65M	$49.16M	$58.25M	$67.01M	$69.64M	$52.66M	$44.82M	$41.73M	$39.25M	$34.86M	$34.92M	$19.69M	$28.90M
Low Forecast	$39.87M	$40.98M	$39.86M	$39.22M	$36.84M	$34.98M	$36.36M	$39.45M	$45.38M	$49.13M	$58.25M	$67.01M	$68.55M	$52.66M	$41.06M	$38.23M	$35.96M	$34.86M	$34.92M	$13.13M	$28.90M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	631371.20%	668959.83%	0.79%	0.83%	1.00%	0.70%	0.82%	1.61%	1.06%

DocGo's average Quarter SG&A projection for Mar 24 is $67.01M, based on 4 Wall Street analysts, with a range of $67.01M to $67.01M. The forecast indicates a -100.00% fall compared to DCGO last annual SG&A of $43.72T (Dec 23).

DocGo EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
# Analysts	2	2	2	2	1	1	1	4	5	4	4	4	5	4	4	4	3	3	3	3	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$131.73K	$-0.02	$-0.04	$0.08	$0.02	$0.13	$0.11	$0.20
Avg Forecast	$0.04	$0.04	$0.04	$0.04	$0.02	$0.02	$0.01	$0.02	$0.04	$0.04	$0.06	$0.08	$0.10	$0.06	$0.03	$0.02	$0.07	$0.05	$0.04	$0.05	$1.89
High Forecast	$0.04	$0.04	$0.04	$0.04	$0.03	$0.02	$0.01	$0.02	$0.04	$0.04	$0.06	$0.08	$0.13	$0.06	$0.03	$0.02	$0.08	$0.05	$0.04	$0.05	$1.89
Low Forecast	$0.04	$0.04	$0.04	$0.04	$0.02	$0.02	$0.01	$0.02	$0.03	$0.04	$0.05	$0.07	$0.07	$0.06	$0.03	$0.02	$0.07	$0.05	$0.04	$0.05	$1.89
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	2136203.64%	-0.69%	-2.15%	1.13%	0.55%	3.56%	2.18%	0.11%

According to 5 Wall Street analysts, DocGo's projected average Quarter EPS for Dec 23 is $0.10, with a low estimate of $0.07 and a high estimate of $0.13. This represents a -100.00% decrease compared to DCGO previous annual EPS of $131.73K (Sep 23).

DocGo Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SEM	Select Medical	$19.12	$40.00	109.21%	Buy
DCGO	DocGo	$4.39	$8.75	99.32%	Buy
MODV	ModivCare	$14.10	$27.33	93.83%	Buy
INNV	InnovAge	$4.08	$6.80	66.67%	Hold
PNTG	Pennant Group	$29.21	$34.67	18.69%	Buy
HCSG	Healthcare Services Group	$11.80	$14.00	18.64%	Hold
EHAB	Enhabit	$8.29	$9.50	14.60%	Hold
ENSG	Ensign Group	$140.00	$159.00	13.57%	Buy
EHC	Encompass Health	$96.94	$107.50	10.89%	Buy
MD	Pediatrix Medical Group	$14.22	$13.50	-5.06%	Hold

DCGO Forecast FAQ

Is DocGo a good buy?

Yes, according to 2 Wall Street analysts, DocGo (DCGO) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of DCGO's total ratings.

What is DCGO's price target?

DocGo (DCGO) average price target is $8.75 with a range of $5 to $11, implying a 104.92% from its last price of $4.27. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will DocGo stock go up soon?

According to Wall Street analysts' prediction for DCGO stock, the company can go up by 104.92% (from the last price of $4.27 to the average price target of $8.75), up by 157.61% based on the highest stock price target, and up by 17.10% based on the lowest stock price target.

Can DocGo stock reach $6?

DCGO's average twelve months analyst stock price target of $8.75 supports the claim that DocGo can reach $6 in the near future.

What are DocGo's analysts' financial forecasts?

DocGo's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $427.57M (high $444.47M, low $414.1M), average EBITDA is $-19.593M (high $-18.976M, low $-20.368M), average net income is $7.44M (high $7.92M, low $7.07M), average SG&A $152.44M (high $158.47M, low $147.64M), and average EPS is $0.07 (high $0.0745, low $0.0665). DCGO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $466.58M (high $489.67M, low $448.57M), average EBITDA is $-21.38M (high $-20.555M, low $-22.438M), average net income is $17.01M (high $18.1M, low $16.15M), average SG&A $166.35M (high $174.58M, low $159.93M), and average EPS is $0.16 (high $0.17, low $0.152).

Did the DCGO's actual financial results beat the analysts' financial forecasts?

Based on DocGo's last annual report (Dec 2023), the company's revenue was $624.29T, beating the average analysts forecast of $573.21M by 108911581.19%. Apple's EBITDA was $34.41T, missing the average prediction of $-26.267M by -131001027.72%. The company's net income was $22.54T, beating the average estimation of $21.87M by 103064530.91%. Apple's SG&A was $139.95T, beating the average forecast of $204.37M by 68481539.03%. Lastly, the company's EPS was $213.39K, beating the average prediction of $0.206 by 103721137.69%. In terms of the last quarterly report (Dec 2023), DocGo's revenue was $199.25T, beating the average analysts' forecast of $194.21M by 102591133.80%. The company's EBITDA was $16.82T, missing the average prediction of $-8.9M by -188980032.18%. DocGo's net income was $16.4T, beating the average estimation of $10.45M by 156904334.46%. The company's SG&A was $43.72T, beating the average forecast of $69.24M by 63137019.63%. Lastly, the company's EPS was $0, missing the average prediction of $0.0983 by -100.00%